Cost-Based Pricing For Innovative Medicines Is Unviable And Harmful : vimarsana.com

A flawed study on diabetes medicines attempts to justify using cost-based pricing to value innovative medicines. Such an approach harms patients and increases spending.

Related Keywords

Cuba , United States , Cuban , Americans , American , Bernie Sanders , Kaiser Family Foundation , American Enterprise Institute , American Diabetes Association , Network Open , Schaeffer Institute , Senator Bernie , Cost Plus Drugs ,